Sign in
4

Changes in Ownership

CytomX Therapeutics, Inc. Filed Acc 0000899243-16-034052

Director sold 45,324 shares at an average $11.61 ($526,088)

From the SEC's structured data for this filing

Trades in this filing

Canaan IX L.P. · Director

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2016-11-17 Sale : show line 1 in the form −18,971 $11.50 $218,218 3,773,829 I
2016-11-18 Sale : show line 2 in the form −12,805 $11.64 $149,085 3,761,024 I
2016-11-21 Sale : show line 3 in the form −13,548 $11.72 $158,785 3,747,476 I
Open-market sales · 45,324 sh · avg $11.61 · $526,088
Loading xslF345X03/doc4.xml…